A detailed history of Headlands Technologies LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 39,708 shares of PGEN stock, worth $183,053. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,708
Previous 23,714 67.45%
Holding current value
$183,053
Previous $33,000 293.94%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$1.43 - $4.76 $22,871 - $76,131
15,994 Added 67.45%
39,708 $130,000
Q2 2025

Aug 14, 2025

SELL
$1.17 - $1.62 $40,551 - $56,147
-34,659 Reduced 59.38%
23,714 $33,000
Q1 2025

May 09, 2025

BUY
$1.07 - $2.03 $62,459 - $118,497
58,373 New
58,373 $86,000
Q2 2023

Aug 03, 2023

BUY
$0.96 - $1.4 $13,117 - $19,129
13,664 New
13,664 $15,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $960M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.